Precigen (PGEN) Change in Inventory (2014 - 2026)

Precigen (PGEN) reported Change in Inventory of $4.9 million for Q1 2026, down 22.07% quarter-over-quarter from $6.3 million in Q4 2025.

Precigen (PGEN) Change in Inventory (2014 - 2026) Analysis & Trends

Precigen (PGEN) has 11 years of Change in Inventory data on file, last reported at $4.9 million in Q1 2026.

Change in Inventory for Q1 2026 came in at $4.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $11.1 million (up 808.65% YoY), and the FY2025 annual result was $9.2 million, changed N/A from the prior year.
Change in Inventory fell to $4.9 million in Q1 2026 per PGEN's latest filing, from $6.3 million in the prior quarter.
Over five years, Change in Inventory peaked at $6.3 million in Q4 2025 and troughed at -$1.6 million in Q3 2022.
A 3-year average of $1.5 million and a median of -$85500.0 in 2022 frame the typical range for Change in Inventory.
On a YoY basis, Change in Inventory climbed as much as 26.35% in 2022 and fell as far as 130.71% in 2022.
A 3-year view of Change in Inventory shows it stood at $67000.0 in 2022, then jumped by 9244.78% to $6.3 million in 2025, then dropped by 22.07% to $4.9 million in 2026.
Business Quant data shows PGEN's Change in Inventory at $4.9 million in Q1 2026, $6.3 million in Q4 2025, and $67000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change Inventory (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	51,468.00
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	97.70 Mn
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Precigen	1.27 Bn	1.27 Bn	20.69 Mn	4.88 Mn

Download Data